|
Volumn 57, Issue 5, 2002, Pages 291-300
|
Formulation approaches for orally administered poorly soluble drugs
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACYLGLYCEROL;
AMPHOTERICIN B;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ATOVAQUONE;
BILE SALT;
CELLULOSE DERIVATIVE;
CHELATING AGENT;
CLOROCIL;
CYCLODEXTRIN;
CYCLODEXTRIN DERIVATIVE;
CYCLOSPORIN A;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DRUG;
EMULSIFYING AGENT;
FATTY ACID;
FENBUFEN;
GLIBENCLAMIDE;
GRISEOFULVIN;
IBUPROFEN;
ITRACONAZOLE;
LIPID;
MACROGOL;
OXAZEPAM;
PACLITAXEL;
POLYACRYLIC ACID;
POLYOL;
POVIDONE;
SALICYLIC ACID DERIVATIVE;
SOLVENT;
SURFACTANT;
UNINDEXED DRUG;
COMPLEX FORMATION;
CRYSTAL;
DRUG ABSORPTION;
DRUG CLASSIFICATION;
DRUG DELIVERY SYSTEM;
DRUG DIFFUSION;
DRUG FORMULATION;
DRUG PENETRATION;
DRUG SOLUBILITY;
EMULSION;
MICELLE;
PARTICLE SIZE;
PHARMACEUTICS;
REVIEW;
SUSPENSION;
THEORY;
THICKNESS;
BIOPHARMACEUTICS;
CHEMISTRY, PHARMACEUTICAL;
CHEMISTRY, PHYSICAL;
EXCIPIENTS;
PERMEABILITY;
SOLUBILITY;
|
EID: 0036096613
PISSN: 00317144
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (71)
|
References (93)
|